CARGO Therapeutics, Inc (CRGX): יחס מחיר להכנסות

סמל ולוגו של המותג Cargo Therapeutics (CRGX)

The strategic goal of CARGO Therapeutics (CRGX) is to create an effective CAR-T therapy against lymphomas supported by high-quality biomanufacturing. The market cap-to-revenue ratio on the GURU.Markets chart captures the implementation stage of this objective, where the parameter value equals . Revenues are based on insurance payments for blood treatment; however, a high cash burn rate and trial complexities create significant financial barriers.

CRGX: מכפיל P/S CARGO Therapeutics 04.07.2022 - 17.11.2026

פילוחי מדדים ואנליטיקה של חברת CARGO Therapeutics, Inc. (CRGX)

- מחיר נוכחי ושווי מניות חזוי:
ניתוח כללי של החברה:CRGX - Cargo Therapeutics
מוצר סדרתי של cargo-tx.com

For CARGO Therapeutics (CRGX), operating in the high-risk domain of CAR-T therapy development, the price-to-sales ratio serves as an indicator of market expectations regarding clinical trial success. The P/S ratio correlates the company's market capitalization with annual sales volume, making it possible to determine the degree of overpayment for the asset or the risk of capital stagnation amid fierce competition for patent superiority.